Literature DB >> 21605889

Cytotoxicity and physicochemical properties of hafnium oxide nanoparticles.

James A Field1, Antonia Luna-Velasco, Scott A Boitano, Farhang Shadman, Buddy D Ratner, Chris Barnes, Reyes Sierra-Alvarez.   

Abstract

Nano-sized hafnium oxide (HfO(2)) particles are being considered for applications within the semiconductor industry. However, little is known about their cytotoxicity. The objective of this work was to assess several HfO(2) nanoparticles (NPs) samples for their acute cytotoxicity. Dynamic light scattering analysis of the samples indicated that the average particle size of the HfO(2) in aqueous dispersions was in the submicron range with a fraction of particles having nano-dimensions. The media used in the toxicity assays decreased or increased the average particle size of HfO(2) NPs due to dispersion or agglomeration. Static time-of-flight secondary ion mass spectrometry (ToF-SIMS) revealed numerous surface contaminants on the NPs. Only one HfO(2) sample caused moderate cytotoxicity to human cell lines. The inhibitory sample caused a 50% response in the Live/Dead assay with HaCaT skin cells at 2200 mg L(-1); and a 50% response in the mitochondrial toxicity test at 300 mg L(-1). A microbial inhibition assay based on methanogenic activity also revealed that another HFO(2) sample caused moderate inhibition. The difference in toxicity between samples could not be attributed to size. Instead the difference in toxicity was likely due to differences in the contaminants of the HfO(2). The ToF-SIMS analysis indicated unique signatures of Br and P in the sample toxic to human cell lines suggesting a distinct synthesis was used for that sample which may have been accompanied by inhibitory impurities. The results taken as a whole indicate that HfO(2) itself is relatively non-toxic.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605889     DOI: 10.1016/j.chemosphere.2011.04.067

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  7 in total

Review 1.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 2.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

Review 3.  Nanomedicine in chemoradiation.

Authors:  Seth M Miller; Andrew Z Wang
Journal:  Ther Deliv       Date:  2013-02

Review 4.  High-Z Metal-Organic Frameworks for X-ray Radiation-Based Cancer Theranostics.

Authors:  Megan J Neufeld; Alec Lutzke; Guillem Pratx; Conroy Sun
Journal:  Chemistry       Date:  2020-12-15       Impact factor: 5.236

5.  A novel approach to low-temperature synthesis of cubic HfO2 nanostructures and their cytotoxicity.

Authors:  Neeraj Kumar; Blassan Plackal Adimuriyil George; Heidi Abrahamse; Vyom Parashar; Suprakas Sinha Ray; Jane Catherine Ngila
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 6.  Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells.

Authors:  Yan Liu; Pengcheng Zhang; Feifei Li; Xiaodong Jin; Jin Li; Weiqiang Chen; Qiang Li
Journal:  Theranostics       Date:  2018-02-12       Impact factor: 11.556

7.  Hafnium (IV) oxide obtained by atomic layer deposition (ALD) technology promotes early osteogenesis via activation of Runx2-OPN-mir21A axis while inhibits osteoclasts activity.

Authors:  A Seweryn; M Alicka; A Fal; K Kornicka-Garbowska; K Lawniczak-Jablonska; M Ozga; P Kuzmiuk; M Godlewski; K Marycz
Journal:  J Nanobiotechnology       Date:  2020-09-15       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.